PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28741799-5	2017	RESULT: Baseline HMGB-1 was significantly higher in the BHT (+) group than in the BHT (-) group.	Butylated Hydroxytoluene	56-59	high mobility group box 1	Homo sapiens	17-23	
28741799-5	2017	RESULT: Baseline HMGB-1 was significantly higher in the BHT (+) group than in the BHT (-) group.	Butylated Hydroxytoluene	82-85	high mobility group box 1	Homo sapiens	17-23	
28741799-6	2017	Thereafter, HMGB-1 in the BHT (+) group significantly decreased at 24 h intervals, reaching the reference range by 2 days of age.	Butylated Hydroxytoluene	26-29	high mobility group box 1	Homo sapiens	12-18	
28741799-7	2017	In the BHT (+) group, when patients were classified into clinically significant neurological disorder due to HIE (+) and (-) according to MRI, the neurological disorder (+) group had higher mean HMGB-1.	Butylated Hydroxytoluene	7-10	high mobility group box 1	Homo sapiens	195-201	
28741799-8	2017	CONCLUSIONS: In HIE, HMGB-1 differs according to the presence of BHT, suggesting that HMGB-1 measurement soon after birth might be useful for determining BHT necessity and short-term outcome.	Butylated Hydroxytoluene	65-68	high mobility group box 1	Homo sapiens	21-27	
28741799-8	2017	CONCLUSIONS: In HIE, HMGB-1 differs according to the presence of BHT, suggesting that HMGB-1 measurement soon after birth might be useful for determining BHT necessity and short-term outcome.	Butylated Hydroxytoluene	65-68	high mobility group box 1	Homo sapiens	86-92	
28741799-8	2017	CONCLUSIONS: In HIE, HMGB-1 differs according to the presence of BHT, suggesting that HMGB-1 measurement soon after birth might be useful for determining BHT necessity and short-term outcome.	Butylated Hydroxytoluene	154-157	high mobility group box 1	Homo sapiens	21-27	
28741799-8	2017	CONCLUSIONS: In HIE, HMGB-1 differs according to the presence of BHT, suggesting that HMGB-1 measurement soon after birth might be useful for determining BHT necessity and short-term outcome.	Butylated Hydroxytoluene	154-157	high mobility group box 1	Homo sapiens	86-92	
28741799-1	2017	BACKGROUND: We measured changes in the blood level of high-mobility group box-1 (HMGB-1) at 24 h intervals in neonates treated with brain/body hypothermia (body hypothermia therapy: BHT) for hypoxic-ischemic encephalopathy (HIE), to evaluate the usefulness of HMGB-1 level for determining outcomes.	Butylated Hydroxytoluene	182-185	high mobility group box 1	Homo sapiens	54-79	
28741799-1	2017	BACKGROUND: We measured changes in the blood level of high-mobility group box-1 (HMGB-1) at 24 h intervals in neonates treated with brain/body hypothermia (body hypothermia therapy: BHT) for hypoxic-ischemic encephalopathy (HIE), to evaluate the usefulness of HMGB-1 level for determining outcomes.	Butylated Hydroxytoluene	182-185	high mobility group box 1	Homo sapiens	81-87	
24191125-6	2013	The UA-HMGB1 level in the BHT (-) group did not differ significantly from reference values, but was significantly increased 24 hours after birth.	Butylated Hydroxytoluene	26-29	high mobility group box 1	Homo sapiens	7-12